GWS
PACB icon

Glassman Wealth Services’s Pacific Biosciences PACB Stock Holding History

Glassman Wealth Services’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-66
Closed -$2K – 1829
2021
Q3 		$2K Buy
+66
New +$1.96K ﹤0.01% 1198
2020
Q1 		– Sell
-109
Closed -$1K – 1444
2019
Q4 		$1K Buy
+109
New +$554 ﹤0.01% 994
2019
Q3 		– Sell
-31
Closed – – 1292
2019
Q2 		$0 Buy
+31
New +$217 ﹤0.01% 1290

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Glassman Wealth Services's PACB Position: Q4 2021 in Review

Glassman Wealth Services sold out of Pacific Biosciences (PACB) in Q4 2021, closing a stake of 66 shares — an estimated $2K sold.

Glassman Wealth Services first reported a position in PACB in Q2 2019 and held it in 3 quarters. The position peaked at $2K in Q3 2021. 255 funds tracked by Wall St. Rank hold PACB as of Q4 2021.

  • Glassman Wealth Services reported no remaining Pacific Biosciences position as of Q4 2021 after selling out during the quarter.
  • Glassman Wealth Services sold 66 Pacific Biosciences shares in Q4 2021, an estimated $2K.
  • Glassman Wealth Services first reported a position in Pacific Biosciences in Q2 2019 and held it in 3 quarters.
  • Glassman Wealth Services's Pacific Biosciences position peaked at $2K in Q3 2021.
  • 255 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2021.

Based on Glassman Wealth Services's 13F filing for Q4 2021, filed 14 Feb 2022.